BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 22435424)

  • 21. [Extramedullary initial manifestations of acute myeloid leukemia (AML)].
    Schmitt-Gräff A; Wickenhauser C; Kvasnicka HM; Dries V; Thiele J
    Pathologe; 2002 Nov; 23(6):397-404. PubMed ID: 12436291
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Skin involvement in myelogenous leukemia: morphologic and immunophenotypic heterogeneity of skin infiltrates.
    Kaiserling E; Horny HP; Geerts ML; Schmid U
    Mod Pathol; 1994 Sep; 7(7):771-9. PubMed ID: 7824512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myelogenous leukemia cutis resembling stasis dermatitis.
    Chang HY; Wong KM; Bosenberg M; McKee PH; Haynes HA
    J Am Acad Dermatol; 2003 Jul; 49(1):128-9. PubMed ID: 12833025
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathologic sideroblastosis in myelodysplastic syndromes and acute nonlymphocytic leukemia.
    Bernardeschi P; Bonechi I
    Recenti Prog Med; 1991 Nov; 82(11):588-90. PubMed ID: 1763231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disappearing myelodysplastic syndrome-associated hemolytic anemia in leukemic transformation.
    Tabata R; Tabata C; Omori K; Nagai T
    Int Arch Allergy Immunol; 2010; 152(4):407-12. PubMed ID: 20197683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognosis of secondary acute myeloid leukemia is affected by the type of the preceding hematologic disorders and the presence of trisomy 8.
    Koh Y; Kim I; Bae JY; Song EY; Kim HK; Yoon SS; Lee DS; Park SS; Park MH; Park S; Kim BK
    Jpn J Clin Oncol; 2010 Nov; 40(11):1037-45. PubMed ID: 20587614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myeloid sarcoma developing in pre-existing pyoderma gangrenosum.
    Kristensen IB; Møller H; Kjaerskov MW; Yderstraede K; Møller MB; Bergmann OJ
    Acta Derm Venereol; 2009; 89(2):175-7. PubMed ID: 19326005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic recurrent lymphocytic Sweet syndrome as a predictive marker of myelodysplasia: a report of 9 cases.
    Vignon-Pennamen MD; Juillard C; Rybojad M; Wallach D; Daniel MT; Morel P; Verola O; Janin A
    Arch Dermatol; 2006 Sep; 142(9):1170-6. PubMed ID: 16983004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cutaneous alternariosis revealing acute myeloid leukaemia in an adult patient.
    Ioannidou D; Maraki S; Krüger Krasagakis S; Stefanidou M; Krasagakis K; Alexandrakis M; Tosca A
    Mycoses; 2004 Jun; 47(5-6):227-30. PubMed ID: 15189189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A case of monocytic leukaemia cutis in a patient with myelodysplastic syndrome transforming to acute myeloid leukaemia.
    Perez A; Kennedy C; Standen G; Oxley J
    Clin Exp Dermatol; 2004 Sep; 29(5):497-8. PubMed ID: 15347335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aleukemic leukemia cutis preceding overt acute myeloid leukemia in myelodysplastic syndrome.
    Rodríguez JN; Fernandez-Jurado A; Navarro A; Martino ML; Prados D
    Am J Hematol; 1997 Jan; 54(1):91-2. PubMed ID: 8980276
    [No Abstract]   [Full Text] [Related]  

  • 32. Expression of JL1 is an effective adjunctive marker of leukemia cutis.
    Park YS; Park SH; Park SJ; Kim Y; Jang KT; Ko YH; Lee MW; Huh JR; Park CS
    Arch Pathol Lab Med; 2010 Jan; 134(1):95-102. PubMed ID: 20073611
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leukemic cluster growth in culture is an independent risk factor for acute myeloid leukemia and short survival in patients with myelodysplastic syndrome.
    Bernimoulin M; Stern M; Tichelli A; Jotterand M; Gratwohl A; Nissen C
    Acta Haematol; 2008; 119(4):226-35. PubMed ID: 18566541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone marrow leukaemic transformation of myelodysplastic syndrome revealed by a cutaneous Langerhans cell infiltrate: partial response to azacitidine.
    Osio A; Elfatoiki F; Raffoux E; Vignon-Pennamen MD; de Labarthe A; Cordoliani F; Petrella T; Bagot M; Janin A; Battistella M; Bouaziz JD
    Eur J Dermatol; 2013; 23(5):710-1. PubMed ID: 24125873
    [No Abstract]   [Full Text] [Related]  

  • 35. Frequent p53 overexpression in therapy related myelodysplastic syndromes and acute myeloid leukemias: an immunohistochemical study of bone marrow biopsies.
    Orazi A; Cattoretti G; Heerema NA; Sozzi G; John K; Neiman RS
    Mod Pathol; 1993 Sep; 6(5):521-5. PubMed ID: 8248107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Specific and nonspecific skin manifestations in leukemia].
    Büchner SA
    Praxis (Bern 1994); 2002 Jun; 91(24):1071-7. PubMed ID: 12109056
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Concurrent Sweet's syndrome and leukemia cutis in patients with myeloid disorders.
    del Pozo J; Martínez W; Pazos JM; Yebra-Pimentel MT; García Silva J; Fonseca E
    Int J Dermatol; 2005 Aug; 44(8):677-80. PubMed ID: 16101872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cutaneous symptoms revealing acute myeloid leukemia].
    Ben Dhaou Hmaidi B; Boussema F; Baili L; Ketari S; Aydi Z; Cherif O; Rokbani L
    Tunis Med; 2011 Dec; 89(12):946-7. PubMed ID: 22198880
    [No Abstract]   [Full Text] [Related]  

  • 39. [Choroid infiltration in myelodysplastic syndrome].
    Madjlessi F; Dann K; Althaus C; Sundmacher R; Meckenstock G
    Klin Monbl Augenheilkd; 1998 Jul; 213(1):51-4. PubMed ID: 9743940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD34/CD117 positivity in assessment of prognosis in children with myelodysplastic syndrome.
    Tavil B; Cetin M; Tuncer M
    Leuk Res; 2006 Feb; 30(2):222-4. PubMed ID: 16098587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.